What’s the Problem?
This FDA Recall began on Dec. 9, 2020, and affects:
- 1000 Count Trazodone Tablets, USP — Lot# 36783 — Expiration Date 06/2022 — NDC# 42291-834
- 100 Count Sildenafil Tablets, USP — Lot# 36884 — Expiration Date 03/2022 — NDC# 42291-748
“These products have been recalled due to a product mix-up of the listed two separate products inadvertently packaged together during bottling at a 3rd party facility,” FDA said. “Unintended intake of trazodone may result in adverse health consequences such as somnolence/sedation, dizziness, constipation, and blurred vision.”
Trazodone hydrochloride is indicated for the treatment of major depressive disorder and sildenafil is a PDE-5 inhibitor which is used for the treatment of erectile dysfunction (ED).
The recalled medications were distributed to distributors and wholesalers, and then further distributed nationwide.
Consumers who were prescribed any recalled trazodone or sildenafil should contact their physician for replacement medication.
Anyone concerned about a potential adverse reaction to prescription medications should contact their healthcare provider immediately.
Do I Have a Trazodone Recall Class Action Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Trazodone Lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
If you or another loved one was injured by recalled Trazodone, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.